Original Research

Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease

Ichinose M, Takizawa A, Izumoto T, Tadayasu Y, Hamilton AL, Kunz C, Fukuchi Y

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1673-1683

Published Date: 20 August 2015